Related Experiment Videos
Pediatric respiratory infections by Mycoplasma pneumoniae
1Department of Pediatrics, The Catholic University of Korea, Daejeon St Mary's Hospital, 520-2 Daeheung 2-dong, Jung-gu, Daejeon 301-723, Republic of Korea. leekyungyil@catholic.ac.kr
Abstract:
Mycoplasma pneumoniae is one of the most common agents of community-acquired pneumonia in children and young adults. Although M. pneumoniae is a small bacterium that can reproduce in an artificial culture medium and is known to be sensitive to certain antibiotics in vitro as well as in vivo, the immunopathogenesis of M. pneumoniae in the human host is not fully understood. The epidemiologic characteristics, including periodic epidemics, and some clinical characteristics of M. pneumoniae are similar to those observed in systemic viral infections. Many experimental and clinical studies have suggested that the pathogenesis of lung injuries in M. pneumoniae infection is associated with a cell-mediated immune reaction, including high responsiveness to corticosteroid therapy. This paper presents an overview of M. pneumoniae infections, with emphasis on epidemiology, pathogenesis and treatment.
Insights
Mycoplasma pneumoniae causes community-acquired pneumonia. Its immunopathogenesis involves cell-mediated immunity and responds to corticosteroids, though not fully understood.
Area of Science:
- Infectious Diseases
- Immunology
- Pediatrics
Background:
- Mycoplasma pneumoniae is a common cause of pneumonia in children and young adults.
- Its immunopathogenesis in humans remains incompletely understood.
- Epidemiological and clinical features resemble systemic viral infections.
Purpose of the Study:
- To provide an overview of Mycoplasma pneumoniae infections.
- To emphasize epidemiology, pathogenesis, and treatment strategies.
- To highlight the role of cell-mediated immunity.
Main Methods:
- Literature review of experimental and clinical studies.
- Analysis of epidemiological data on M. pneumoniae outbreaks.
- Examination of clinical characteristics and treatment responses.
Main Results:
- M. pneumoniae infections exhibit periodic epidemic patterns.
- Lung injury pathogenesis is linked to cell-mediated immune responses.
- Corticosteroid therapy shows significant responsiveness.
Conclusions:
- Understanding M. pneumoniae immunopathogenesis is crucial for effective treatment.
- Cell-mediated immunity plays a key role in lung injury.
- Further research is needed to fully elucidate host-pathogen interactions.
Related Concept Videos
Atypical Pneumonia
Respiratory Syncytial Virus Disease
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Microbiota of the Respiratory Tract
Pneumonia III: Complications and Assessment